Tekmira Pharmaceuticals Corp (TKMR) 20.70 $TKMR
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan
at The Street - Fri Aug 08, 7:15PM CDT
Cramer's watching earnings next week as he seeks stocks worth buying, not selling, in this market.
Nasdaq stocks posting largest volume increases
AP - Fri Aug 08, 5:06PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Nasdaq stocks posting largest percentage increases
AP - Fri Aug 08, 5:06PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Most active Nasdaq-traded stocks
AP - Fri Aug 08, 5:06PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
Gap and Post Holdings are big market movers
AP - Fri Aug 08, 3:36PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
Why Tekmira Pharmaceuticals (TKMR) Stock Is Soaring Today (Update)
at The Street - Fri Aug 08, 3:36PM CDT
Tekmira Pharmaceuticals (TKMR) soared Friday after the company announced Thursday afternoon the Food & Drug Administration had loosened its clinical hold on the company's developmental ebola drug, TKM-Ebola.
3 Biotech Stocks to End Q2 on a Winning Note - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Fri Aug 08, 2:54PM CDT
The rebound was due to strong earnings reports, product approvals, and acquisitions and licensing deals.
Tekmira Ebola Drug Hold Lifted By FDA, Stock Soars
at Investor's Business Daily - Fri Aug 08, 1:04PM CDT
Biotech firm Tekmira Pharmaceuticals vaulted more than 39% in huge volume during afternoon trading on the stock market today after the FDA partially lifted a hold on its drug candidate for treating Ebola. Tekmira's (TKMR) drug, TKM-Ebola, is in a...
Stock Futures Steer Higher; MercadoLibre And Tekmira Soar
at Investor's Business Daily - Fri Aug 08, 8:14AM CDT
Stock futures upshifted early Friday, as investors weighed positive Q2 productivity numbers against U.S. military action in Iraq. Dow futures rose 49.7 points above fair market value. Nasdaq 100 futures pounded out a 12.7 point gain. S&P 500 futures...
IIROC Trade Resumption - Tekmira Pharmaceuticals Corporation
Newsfile Corp - Fri Aug 08, 7:14AM CDT
Trading resumes in:
'Fast Money' Recap: Still Pressured by Russia
at The Street - Fri Aug 08, 4:00AM CDT
The trading panel discussed the deteriorating situation on the Ukraine border and its effect on U.S. and international stocks.
Tekmira Conference Call and Webcast Advisory: Corporate Update and Second Quarter Financial Results
GlobeNewswire - Thu Aug 07, 7:36PM CDT
Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced that it will hold a conference call and webcast on Wednesday, August 13, 2014 at 2 p.m. Pacific Time (5 p.m. Eastern Time) to provide a corporate update and report financial results for the second quarter ended June 30, 2014.
FDA lifts hold on experimental Ebola drug
By MATTHEW PERRONE - AP - Thu Aug 07, 6:26PM CDT
WASHINGTON (AP) — U.S. health authorities have eased safety restrictions on an experimental drug to treat Ebola, a move that could clear the way for its use in patients infected with the deadly virus.
TEKMIRA PHARMA
at Investor's Business Daily - Thu Aug 07, 6:00PM CDT
TEKMIRA PHARMA (TKMR) said it got verbal FDA confirmation modifying the July block placed on human trials of its Ebola drug. Shares rose 6.5% to 15.20.
FDA Modifies Tekmira's TKM-Ebola Clinical Hold to Partial Hold
GlobeNewswire - Thu Aug 07, 3:45PM CDT
Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today announced that the U.S. Food & Drug Administration (FDA) has verbally confirmed they have modified the full clinical hold placed on the TKM-Ebola Investigational New Drug Application (IND) to a partial clinical hold. This action enables the potential use of TKM-Ebola in individuals infected with Ebola virus.
IIROC Trade Halt - Tekmira Pharmaceuticals Corporation
Newsfile Corp - Thu Aug 07, 3:07PM CDT
The following issues have been halted by IIROC:
Sarepta Should Shut Up About Ebola, Focus on Job No. 1
at The Street - Wed Aug 06, 11:07AM CDT
By publicizing its outreach to the U.S. government about an experimental ebola treatment, Sarepta comes off looking like just another opportunistic, self-promoting drug developer.
Biotech Stock Roundup: Amgen Plans Job Cuts, Regeneron's Eylea Continues to Impress - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Aug 06, 11:00AM CDT
Among the earnings reports, the Ebola outbreak has brought quite a few biotech companies into the limelight for their experimental Ebola disease treatments.
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan
at The Street - Fri Aug 08, 7:15PM CDT
Cramer's watching earnings next week as he seeks stocks worth buying, not selling, in this market.
Nasdaq stocks posting largest volume increases
AP - Fri Aug 08, 5:06PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Nasdaq stocks posting largest percentage increases
AP - Fri Aug 08, 5:06PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Most active Nasdaq-traded stocks
AP - Fri Aug 08, 5:06PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
Gap and Post Holdings are big market movers
AP - Fri Aug 08, 3:36PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
Why Tekmira Pharmaceuticals (TKMR) Stock Is Soaring Today (Update)
at The Street - Fri Aug 08, 3:36PM CDT
Tekmira Pharmaceuticals (TKMR) soared Friday after the company announced Thursday afternoon the Food & Drug Administration had loosened its clinical hold on the company's developmental ebola drug, TKM-Ebola.
3 Biotech Stocks to End Q2 on a Winning Note - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Fri Aug 08, 2:54PM CDT
The rebound was due to strong earnings reports, product approvals, and acquisitions and licensing deals.
Tekmira Ebola Drug Hold Lifted By FDA, Stock Soars
at Investor's Business Daily - Fri Aug 08, 1:04PM CDT
Biotech firm Tekmira Pharmaceuticals vaulted more than 39% in huge volume during afternoon trading on the stock market today after the FDA partially lifted a hold on its drug candidate for treating Ebola. Tekmira's (TKMR) drug, TKM-Ebola, is in a...
Stock Futures Steer Higher; MercadoLibre And Tekmira Soar
at Investor's Business Daily - Fri Aug 08, 8:14AM CDT
Stock futures upshifted early Friday, as investors weighed positive Q2 productivity numbers against U.S. military action in Iraq. Dow futures rose 49.7 points above fair market value. Nasdaq 100 futures pounded out a 12.7 point gain. S&P 500 futures...
IIROC Trade Resumption - Tekmira Pharmaceuticals Corporation
Newsfile Corp - Fri Aug 08, 7:14AM CDT
Trading resumes in:
'Fast Money' Recap: Still Pressured by Russia
at The Street - Fri Aug 08, 4:00AM CDT
The trading panel discussed the deteriorating situation on the Ukraine border and its effect on U.S. and international stocks.
Tekmira Conference Call and Webcast Advisory: Corporate Update and Second Quarter Financial Results
GlobeNewswire - Thu Aug 07, 7:36PM CDT
Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced that it will hold a conference call and webcast on Wednesday, August 13, 2014 at 2 p.m. Pacific Time (5 p.m. Eastern Time) to provide a corporate update and report financial results for the second quarter ended June 30, 2014.
FDA lifts hold on experimental Ebola drug
By MATTHEW PERRONE - AP - Thu Aug 07, 6:26PM CDT
WASHINGTON (AP) — U.S. health authorities have eased safety restrictions on an experimental drug to treat Ebola, a move that could clear the way for its use in patients infected with the deadly virus.
TEKMIRA PHARMA
at Investor's Business Daily - Thu Aug 07, 6:00PM CDT
TEKMIRA PHARMA (TKMR) said it got verbal FDA confirmation modifying the July block placed on human trials of its Ebola drug. Shares rose 6.5% to 15.20.
FDA Modifies Tekmira's TKM-Ebola Clinical Hold to Partial Hold
GlobeNewswire - Thu Aug 07, 3:45PM CDT
Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today announced that the U.S. Food & Drug Administration (FDA) has verbally confirmed they have modified the full clinical hold placed on the TKM-Ebola Investigational New Drug Application (IND) to a partial clinical hold. This action enables the potential use of TKM-Ebola in individuals infected with Ebola virus.
IIROC Trade Halt - Tekmira Pharmaceuticals Corporation
Newsfile Corp - Thu Aug 07, 3:07PM CDT
The following issues have been halted by IIROC:
Sarepta Should Shut Up About Ebola, Focus on Job No. 1
at The Street - Wed Aug 06, 11:07AM CDT
By publicizing its outreach to the U.S. government about an experimental ebola treatment, Sarepta comes off looking like just another opportunistic, self-promoting drug developer.
Biotech Stock Roundup: Amgen Plans Job Cuts, Regeneron's Eylea Continues to Impress - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Aug 06, 11:00AM CDT
Among the earnings reports, the Ebola outbreak has brought quite a few biotech companies into the limelight for their experimental Ebola disease treatments.
